These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 18987357

  • 21. Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alpha IIb beta 3, alpha V beta 3 and alpha 5 beta 1 and in cell adhesion inhibition.
    Pfaff M, McLane MA, Beviglia L, Niewiarowski S, Timpl R.
    Cell Adhes Commun; 1994 Dec; 2(6):491-501. PubMed ID: 7538018
    [Abstract] [Full Text] [Related]

  • 22. The interaction of integrin αIIbβ3 with fibrin occurs through multiple binding sites in the αIIb β-propeller domain.
    Podolnikova NP, Yakovlev S, Yakubenko VP, Wang X, Gorkun OV, Ugarova TP.
    J Biol Chem; 2014 Jan 24; 289(4):2371-83. PubMed ID: 24338009
    [Abstract] [Full Text] [Related]

  • 23. Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins.
    Marcinkiewicz C, Rosenthal LA, Mosser DM, Kunicki TJ, Niewiarowski S.
    Biochem J; 1996 Aug 01; 317 ( Pt 3)(Pt 3):817-25. PubMed ID: 8760368
    [Abstract] [Full Text] [Related]

  • 24. A mutation in the alpha subunit of the platelet integrin alphaIIbbeta3 identifies a novel region important for ligand binding.
    Tozer EC, Baker EK, Ginsberg MH, Loftus JC.
    Blood; 1999 Feb 01; 93(3):918-24. PubMed ID: 9920841
    [Abstract] [Full Text] [Related]

  • 25. Platelet aggregation inhibition with glycoprotein IIb--IIIa inhibitors.
    Proimos G.
    J Thromb Thrombolysis; 2001 Apr 01; 11(2):99-110. PubMed ID: 11406724
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Positional importance of Pro53 adjacent to the Arg49-Gly50-Asp51 sequence of rhodostomin in binding to integrin alphaIIbbeta3.
    Chang CP, Chang JC, Chang HH, Tsai WJ, Lo SJ.
    Biochem J; 2001 Jul 01; 357(Pt 1):57-64. PubMed ID: 11415436
    [Abstract] [Full Text] [Related]

  • 36. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E, Alexandre A, Cavallini L, Polverino de Laureto P, Rao GH, Doni MG.
    Arch Biochem Biophys; 1996 Sep 15; 333(2):407-13. PubMed ID: 8809080
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition.
    Li YF, Spencer FA, Becker RC.
    Am Heart J; 2002 Apr 15; 143(4):725-32. PubMed ID: 11923812
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Increased ability of tirofiban to maintain its inhibitory effects on the binding of fibrinogen to platelets in blood from patients with and without diabetes mellitus.
    Schneider DJ, Keating FK, Baumann PQ, Whitaker DA, Sobel BE.
    Coron Artery Dis; 2006 Feb 15; 17(1):57-61. PubMed ID: 16374143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.